PHARMACEUTICAL COMPOSITIONS CONTAINING CRYSTALLINE ZIPRASIDONE AND PROCESS FOR PREPARATION OF THE CRYSTALS

Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.

Saved in:
Bibliographic Details
Main Authors ARENSON, DANIEL RAY, HAUSBERGER, ANGELA CAROL GATLIN, BUSCH, FRANK ROBERT, RASADI, BIJAN
Format Patent
LanguageEnglish
Published 02.03.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.
Bibliography:Application Number: HUP9901960